TRIM proteins and cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21979307.
- Also identified by DOI 10.1038/nrc3139.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Emerging clinical evidence shows that the deregulation of ubiquitin-mediated degradation of oncogene products or tumour suppressors is likely to be involved in the aetiology of carcinomas and leukaemias. Recent studies have indicated that some members of the tripartite motif (TRIM) proteins (one of the subfamilies of the RING type E3 ubiquitin ligases) function as important regulators for carcinogenesis. This Review focuses on TRIM proteins that are involved in tumour development and progression.
Medical subject headings
- Cell Transformation, Neoplastic
- Genes, p53
- Neoplasms
- Ubiquitination